AGAP7P

Across TCGA pan-cancer cohorts, AGAP7P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated AGAP7P data layer compared with 6 for mutation status.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher AGAP7P RNA is associated with better overall survival. In most high-consensus cancer types, elevated AGAP7P expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

BLCA, SKCM, and KIRC are the cancer types where AGAP7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	III,IV	0.738	0.569	<.001	73	view →
SKCM	DFS	Quartile	All	0.360	0.109	.001	61	view →
KIRC	OS	Tertile	All	0.492	0.725	<.001	47	view →
HNSC	OS	Tertile	IV	0.824	0.628	.001	44	view →
COAD	DFS	Quartile	III,IV	0.232	0.659	.003	38	view →
PAAD	DFS	Median	II,III,IV	0.521	0.377	.004	27	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	24	view →
UCS	OS	Quartile	III,IV	0.853	0.421	.021	22	view →
SCLC	DFS	Median	II,III,IV	0.821	0.203	.001	21	view →
UVM	OS	Median	All	0.405	0.890	.001	21	view →
THCA	OS	Quartile	III,IV	0.726	1.000	.004	19	view →
LUAD	DFS	Median	II,III,IV	0.635	0.463	.005	19	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

AGAP7P–BLCA (OS)

Open the BLCA breakdown →